68535-61-5Relevant academic research and scientific papers
Lithiation of 2-aryl-2-methyl-1,3-dioxolanes with PMDTA-complexed butyllithium
Nyulasi, Bálint,Németh, András,Porcs-Makkay, Márta,Kupai, József,Lukács, Gyula,Simig, Gyula,Volk, Balázs
, p. 298 - 306 (2017/01/03)
The metalation of chloro- and methoxy-substituted acetophenone ketals with butyllithium (BuLi) and with N,N,N',N″,N″-pentamethyldiethylenetriamine-complexed butyllithium (BuLi/PMDTA) has been investigated. The lithio species thus generated were carboxylat
Compounds for the treatment of metabolic disorders
-
Page/Page column 105, (2016/03/12)
Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
Compounds for the treatment of metabolic disorders
-
, (2008/06/13)
Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
Mass tags for quantitative analysis
-
, (2008/06/13)
The present invention relates generally to novel protein modification reagents for fractionation and quantitative (differential) profiling of proteins in a complex mixture. The reagents react with amino acids or other protein components or structures and function as mass tags. The present invention provides methods of making the protein modification reagents and methods of using the protein modification reagents for quantitative analysis of proteins.
